These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Comparison of seven screening methods in the diagnosis of bladder cancer. Sun Y, He DL, Ma Q, Wan XY, Zhu GD, Li L, Luo Y, He H, Yang L. Chin Med J (Engl); 2006 Nov 05; 119(21):1763-71. PubMed ID: 17097029 [Abstract] [Full Text] [Related]
11. Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer. Sánchez-Carbayo M, Urrutia M, Silva JM, Romaní R, De Buitrago JM, Navajo JA. J Urol; 2001 May 05; 165(5):1462-7. PubMed ID: 11342897 [Abstract] [Full Text] [Related]
20. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer. Kumar A, Kumar R, Gupta NP. Jpn J Clin Oncol; 2006 Mar 01; 36(3):172-5. PubMed ID: 16520358 [Abstract] [Full Text] [Related] Page: [Next] [New Search]